NCT06085534View on ClinicalTrials.gov

A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis

PHASE2CompletedINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

January 6, 2022

Primary Completion Date

December 6, 2022

Study Completion Date

June 20, 2023

Conditions
Ankylosing Spondylitis
Interventions
DRUG

LNK01001

Capsules for oral use

DRUG

Placebo

Capsules for oral use

Trial Locations (1)

Unknown

Peking Union Medical College Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Lynk Pharmaceuticals Co., Ltd

INDUSTRY

NCT06085534 - A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter